Cargando…

Δ(3),2-Hydroxybakuchiol Attenuates Depression in Multiple Rodent Models Possibly by Inhibition of Monoamine Transporters in Brain

Δ(3),2-Hydroxybakuchiol is isolated from Psoralea corylifolia (L.), which has therapeutic applications in traditional Chinese medicine. Our previous studies have showed that Δ(3),2-hydroxybakuchiol inhibited the decreased activity of reserpinized mice, suggestive of its antidepressive potential. In...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Gang, Guo, Li-he, Huang, Wei, Hu, Jia-liang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031082/ https://www.ncbi.nlm.nih.gov/pubmed/30026780 http://dx.doi.org/10.1155/2018/1325141

Ejemplares similares

Synthesis of ∆(3)-2-Hydroxybakuchiol Analogues and Their Growth Inhibitory Activity against Rat UMR106 Cells
por: Zhao, Qun, et al.
Publicado: (2014)

Antidepressant Drugs Transactivate TrkB Neurotrophin Receptors in the Adult Rodent Brain Independently of BDNF and Monoamine Transporter Blockade
por: Rantamäki, Tomi, et al.
Publicado: (2011)

Integrated investigation and discovery of therapeutic targets for 3-hydroxybakuchiol against diabetes based on molecular docking studies and cell experiments
por: Liu, Min, et al.
Publicado: (2023)

In vivo microdialysis and in vitro HPLC analysis of the impact of paeoniflorin on the monoamine levels and their metabolites in the rodent brain
por: Lin, Yuh-Tzy, et al.
Publicado: (2019)

Increased Vesicular Monoamine Transporter 2 (VMAT2) and Dopamine Transporter (DAT) Expression in Adolescent Brain Development: A Longitudinal Micro-PET/CT Study in Rodent
por: Jiang, Donglang, et al.
Publicado: (2019)

Effects of Monoamines and Antidepressants on Astrocyte Physiology: Implications for Monoamine Hypothesis of Depression
por: Marathe, Swananda V, et al.
Publicado: (2018)

Methylone and Monoamine Transporters: Correlation with Toxicity
por: Sogawa, Chiharu, et al.
Publicado: (2011)

Characterization of murine polyspecific monoamine transporters
por: Miura, Yamato, et al.
Publicado: (2017)

The ins and outs of vesicular monoamine transporters
por: Yaffe, Dana, et al.
Publicado: (2018)

The monoaminergic pathways and inhibition of monoamine transporters interfere with the antidepressive-like behavior of ketamine
por: Viana, Glauce Socorro de Barros, et al.
Publicado: (2017)

Inhibition of Monoamine Oxidase by Stilbenes from Rheum palmatum
por: Wei, Bo, et al.
Publicado: (2016)

Para-Halogenation Affects Monoamine Transporter Inhibition Properties and Hepatocellular Toxicity of Amphetamines and Methcathinones
por: Luethi, Dino, et al.
Publicado: (2019)

Extraneuronal Monoamine Transporter Mediates the Permissive Action of Cortisol in the Guinea Pig Trachea: Possible Involvement of Tracheal Chondrocytes
por: Wang, Chen, et al.
Publicado: (2013)

The dual-gate lumen model of renal monoamine transport
por: Hinz, Marty, et al.
Publicado: (2010)

Amphetamines, new psychoactive drugs and the monoamine transporter cycle
por: Sitte, Harald H., et al.
Publicado: (2014)

Monoamine transporters: insights from molecular dynamics simulations
por: Grouleff, Julie, et al.
Publicado: (2015)

Associations Among Monoamine Neurotransmitter Pathways, Personality Traits, and Major Depressive Disorder
por: Shao, Xiaojun, et al.
Publicado: (2020)

An association study between various monoamine transporter gene polymorphisms and treatment response to mirtazapine in major depression
por: Choi, Hong
Publicado: (2010)

Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression
por: JI, XIAO-WEI, et al.
Publicado: (2014)

Inhibition of Activity of GABA Transporter GAT1 by δ-Opioid Receptor
por: Pu, Lu, et al.
Publicado: (2012)

Revisiting the Monoamine Hypothesis of Depression: A New Perspective
por: Goldberg, Joel S, et al.
Publicado: (2014)

[(18)F]CFT synthesis and binding to monoamine transporters in rats
por: Forsback, Sarita, et al.
Publicado: (2012)

Analysis of vesicular monoamine transporter 2 polymorphisms in Parkinson’s disease
por: Brighina, Laura, et al.
Publicado: (2013)

Probing the Selectivity of Monoamine Transporter Substrates by Means of Molecular Modeling
por: Seddik, Amir, et al.
Publicado: (2013)

Designing modulators of monoamine transporters using virtual screening techniques
por: Mortensen, Ole V., et al.
Publicado: (2015)

Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors
por: Caroff, Stanley N.
Publicado: (2020)

Effects of Hydroxylated Mephedrone Metabolites on Monoamine Transporter Activity in vitro
por: Niello, Marco, et al.
Publicado: (2021)

The Dual-Gate Lumen Model of Renal Monoamine Transport [Retraction]
Publicado: (2020)

Effect of Alkaloids Isolated from Phyllodium pulchellum on Monoamine Levels and Monoamine Oxidase Activity in Rat Brain
por: Cai, Lu, et al.
Publicado: (2016)

Exercise Benefits Brain Function: The Monoamine Connection
por: Lin, Tzu-Wei, et al.
Publicado: (2013)

Apigenin attenuates depressive-like behavior via modulating monoamine oxidase A enzyme activity in chronically stressed mice
por: Olayinka, Juliet N., et al.
Publicado: (2023)

Involvement of Organic Cation Transporter-3 and Plasma Membrane Monoamine Transporter in Serotonin Uptake in Human Brain Vascular Smooth Muscle Cells
por: Li, Rachel W. S., et al.
Publicado: (2013)

Prenatal SAMe Treatment Induces Changes in Brain Monoamines and in the Expression of Genes Related to Monoamine Metabolism in a Mouse Model of Social Hierarchy and Depression, Probably via an Epigenetic Mechanism
por: Becker, Maria, et al.
Publicado: (2022)

Uptake of meta-iodobenzylguanidine in neuroendocrine tumours is mediated by vesicular monoamine transporters
por: Kölby, L, et al.
Publicado: (2003)

Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs
por: Han, Dawn D, et al.
Publicado: (2006)

The N Terminus of Monoamine Transporters Is a Lever Required for the Action of Amphetamines
por: Sucic, Sonja, et al.
Publicado: (2010)

Role of Vesicular Monoamine Transporter 2 Inhibitors in Tardive Dyskinesia Management
por: Sreeram, Venkatesh, et al.
Publicado: (2019)

The Dual-Gate Lumen Model of Renal Monoamine Transport [Expression of Concern]
Publicado: (2020)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

Implications for Combination Therapy of Selective Monoamine Reuptake Inhibitors on Dopamine Transporters
por: Ahn, Hyomin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3fcpduofnrugalu0rcnp7tn5qs